Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00891059 · ClinicalTrials.gov registry record
The Role Of Cognitive Impairment In The Use Of The Diskus Inhaler
A clinical trial of Cognitive Impairment, sponsored by Synergy Health Solutions.
- Completed
- Registry status
- 40
- Enrollment target
- 2
- Study locations
NCT00891059 is a study of Cognitive Impairment that has completed, run by Synergy Health Solutions. The registered enrollment target is 40 participants, below the 665-participant average among 105 other Cognitive Impairment trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT00891059, a study of Cognitive Impairment, has completed, sponsored by Synergy Health Solutions.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
- 2
- Study locations
Study Summary
The Diskus Inhaler is administered by a nurse or medical technician in the Nursing Home (NH) setting. The administration of the medication from the Diskus Inhaler includes 4 steps: open, click, inhale, close. The only step that the resident must do is the "inhale" step, which includes holding one's breath for 10 seconds after the inhalation. The investigators propose that properly trained and motivated nurses and medical technicians can successfully administer medication using the Advair Diskus to almost any mildly to moderately cognitively impaired resident who can follow the instruction- "inhale" and hold your breath for 10 seconds". The objective is to show that mild to moderate cognitive impairment should not be a barrier to the use of Diskus Inhaler. There will only be 1 consent visit and 1 evaluation visit per subject.
Conditions Studied
Study Locations (2)
Florida
- Brooksville Health Care Center - Brooksville
Ohio
- Bethany Village - Centerville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2009-05 |
| Est. Completion | 2009-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00891059
The ClinicalTrials.gov registry entry for NCT00891059 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 665-participant average among 105 other Cognitive Impairment trials with a reported enrollment target (94% lower). The listed sponsor is Synergy Health Solutions, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cognitive Impairment appearing as the primary indexed condition, and to 0 interventions.
NCT00891059 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, Ohio.
Frequently Asked Questions
What is clinical trial NCT00891059 about?
NCT00891059 is a clinical study titled "The Role Of Cognitive Impairment In The Use Of The Diskus Inhaler". The Diskus Inhaler is administered by a nurse or medical technician in the Nursing Home (NH) setting. The administration of the medication from the Diskus Inhaler includes 4 steps: open, click, inhale, close. The only step that the resident must do is the "inhale" step, which includes holding one's ...
What is the current status of trial NCT00891059?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2009-05. Estimated completion is 2009-07.
What conditions does trial NCT00891059 study?
This clinical trial studies the following conditions: Cognitive Impairment.
Who is sponsoring clinical trial NCT00891059?
This trial is sponsored by Synergy Health Solutions, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00891059 being conducted?
This trial has 2 study locations across Florida, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cognitive Impairment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS
RECRUITING · NA
-
Mind Your Heart-II
RECRUITING · NA
-
Biomarker Exploration in Aging, Cognition and Neurodegeneration
RECRUITING · Phase 3
-
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
RECRUITING · NA
-
Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistical Pilot Study
RECRUITING · NA
-
Essential Fats For Enhancing Cognitive Thinking (EFFECT) Study
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.